Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1976 1
1977 1
1978 1
1980 2
1981 3
1982 6
1983 2
1984 1
1985 3
1986 3
1987 2
1989 2
1991 1
1992 1
1993 3
1994 3
1995 1
1996 2
1997 4
1998 4
1999 2
2000 3
2001 1
2002 2
2003 3
2005 4
2006 10
2007 8
2008 3
2009 3
2010 6
2011 5
2012 6
2013 7
2014 7
2015 11
2016 12
2017 16
2018 18
2019 15
2020 23
2021 18
2022 20
2023 7
Text availability
Article attribute
Article type
Publication date

Search Results

223 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial.
Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Ogita M, Suwa S, Isawa T, Domei T, Yamaji K, Tatsushima S, Watanabe H, Ohya M, Tokuyama H, Tada T, Sakamoto H, Mori H, Suzuki H, Nishikura T, Wakabayashi K, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 ACS Investigators. Watanabe H, et al. Among authors: ohya m. JAMA Cardiol. 2022 Apr 1;7(4):407-417. doi: 10.1001/jamacardio.2021.5244. JAMA Cardiol. 2022. PMID: 35234821 Free PMC article. Clinical Trial.
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators. Watanabe H, et al. Among authors: ohya m. JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145. JAMA. 2019. PMID: 31237644 Free PMC article. Clinical Trial.
Coronary-Artery Occlusion from Kawasaki's Disease.
Matsuura H, Ohya M. Matsuura H, et al. Among authors: ohya m. N Engl J Med. 2018 Dec 20;379(25):e42. doi: 10.1056/NEJMicm1804902. N Engl J Med. 2018. PMID: 30575487 Free article. No abstract available.
[Molecular targeting therapy in rheumatoid arthritis].
Mima T, Nakashima Y, Hanba Y, Ohya M, Negi S, Shigematsu T. Mima T, et al. Among authors: ohya m. Nihon Jinzo Gakkai Shi. 2012;54(5):603-9. Nihon Jinzo Gakkai Shi. 2012. PMID: 22991840 Review. Japanese. No abstract available.
Multiple primary chordomas of the lung.
Ohya M, Yoshida K, Shimojo H, Shiina T. Ohya M, et al. Respir Med Case Rep. 2018 Aug 21;25:142-144. doi: 10.1016/j.rmcr.2018.08.012. eCollection 2018. Respir Med Case Rep. 2018. PMID: 30175034 Free PMC article.
223 results